Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Apr 13;5(1):20-4.
doi: 10.1102/1470-7330.2005.0005.

MRI in detection of hepatocellular carcinoma (HCC)

Subba R Digumarthy  1 , Dushyant V Sahani, Sanjay Saini
Affiliations
Free PMC article

MRI in detection of hepatocellular carcinoma (HCC)

Subba R Digumarthy et al. Cancer Imaging. .
Free PMC article

Abstract

Hepatocellular carcinoma (HCC) is the commonest malignancy of the liver and is usually due to cirrhosis. Early detection of HCC and the premalignant dysplastic nodules has implications on the management options of tumor ablation, liver resection and transplantation. Magnetic resonance imaging is useful for the detection and characterization of lesions, in the identification of dysplastic nodules and their malignant transformation into HCC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MRI of the dysplastic nodule. (a) T1 weighted image showing a hyperintense dysplastic nodule in the left lobe of the liver. (b) Nodule is characteristically hypointense on T2 weighted image. (c) Non enhancing after IV gadolinium administration.
Figure 2
Figure 2
Small HCC in segment 8 of the liver. (a) T1 weighted image showing a small hypointense nodule adjacent to the right hepatic vein. (b) Nodule is characteristically hyperintense on T2 weighted image. (c) Enhancement during arterial phase after administration of IV gadolinium.
See this image and copyright information in PMC

References

    1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–50. - PubMed
    1. Takayama T, Makuuchi M, Hirohashi S, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet. 1990;336:1150–3. - PubMed
    1. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction on blood supply. Radiology. 1991;178:493–7. - PubMed
    1. Hemming AW, Cattral MS, Reed AI, et al. Liver transplantation for hepatocellular carcinoma. Ann Surg. 2001;233:652–9. - PMC - PubMed
    1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med. 1996;334:693–9. - PubMed

LinkOut - more resources